Search Results - Gannu, Shashikanth

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis

    Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis by Mohamed, Mohamed‐Eslam F., Qian, Yuli, D'Cunha, Ronilda, Sligh, Teresa, Ferris, Laura K., Eldred, Ann, Levy, Gweneth F., Hao, Shuai, Gannu, Shashikanth, Rizzo, David G., Liu, Wei, Jazayeri, Sasha, Sofen, Howard, Carcereri De Prati, Roberto

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Coproporphyrin‐I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug–Drug Interactions: Cedirogant Case Study

    Coproporphyrin‐I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug–Drug Interactions: Cedirogant Case Study by Kikuchi, Ryota, Qian, Yuli, Badawi, Mohamed, Savaryn, John P., Gannu, Shashikanth, Eldred, Ann, Hao, Shuai, Salem, Ahmed Hamed, Liu, Wei, Klein, Cheri E., Mohamed, Mohamed‐Eslam F.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: